No association between genetic variants of the LRRK2 gene and schizophrenia in han chinese

Neuroscience Letters

Volumn 566, Issue , 2014, Pages 210-215

  Li, Xiao ^a,d   Zhang, Wen ^a   Zhang, Chen ^b   Gong, Wei ^a   Tang, Jinsong ^c   Yi, Zhenghui ^b   Wang, Dong ^a   Lu, Weihong ^b   Fang, Yiru ^b   Chen, Xiaogang ^c   Yao, Yong Gang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Han Chinese; LRRK2; Mitochondria; Replication; Schizophrenia; SNP

Indexed keywords

GENOMIC DNA; LEUCINE RICH REPEAT KINASE 2;

ADULT; ALZHEIMER DISEASE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

HAN CHINESE; LRRK2; MITOCHONDRIA; REPLICATION; SCHIZOPHRENIA; SNP;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; PROTEIN-SERINE-THREONINE KINASES; SCHIZOPHRENIA;

EID: 84897852634     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.03.006     Document Type: Article

References (40)

1. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
2. Ben-Shachar D., Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One 2008, 3:e3676.
3. Bi R., Zhao L., Zhang C., Lu W., Feng J.Q., Wang Y., Ni J., Zhang J., Li G.D., Hu Q.X., Wang D., Yao Y.G., Li T. No association of the LRRK2 genetic variants with Alzheimer's disease in Han Chinese individuals. Neurobiol. Aging 2014, 35:444.e5-444.e59.
4. Brown A.S. The environment and susceptibility to schizophrenia. Prog. Neurobiol. 2011, 93:23-58.
5. Choi K.H., Higgs B.W., Weis S., Song J., Llenos I.C., Dulay J.R., Yolken R.H., Webster M.J. Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects. BMC Psychiatry 2009, 9:57.
6. Contreras-Shannon V., Heart D.L., Paredes R.M., Navaira E., Catano G., Maffi S.K., Walss-Bass C. Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells. PLoS One 2013, 8:e59012.
7. Crow T.J. The missing genes: what happened to the heritability of psychiatric disorders?. Mol. Psychiatry 2011, 16:362-364.
8. Dror N., Klein E., Karry R., Sheinkman A., Kirsh Z., Mazor M., Tzukerman M., Ben-Shachar D. State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia. Mol. Psychiatry 2002, 7:995-1001.
9. Gauderman W.J. Sample size requirements for matched case-control studies of gene-environment interaction. Stat. Med. 2002, 21:35-50.
10. Gubert C., Stertz L., Pfaffenseller B., Panizzutti B.S., Rezin G.T., Massuda R., Streck E.L., Gama C.S., Kapczinski F., Kunz M. Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects. J. Psychiatr. Res. 2013, 47:1396-1402.
11. Hatano T., Kubo S., Imai S., Maeda M., Ishikawa K., Mizuno Y., Hattori N. Leucine-rich repeat kinase 2 associates with lipid rafts. Hum. Mol. Genet. 2007, 16:678-690.
12. Holland M.M., Parson W. GeneMarker(R) HID: a reliable software tool for the analysis of forensic STR data. J. Forensic Sci. 2011, 56:29-35.
13. Iwamoto K., Bundo M., Kato T. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum. Mol. Genet. 2005, 14:241-253.
14. Jablensky A. The 100-year epidemiology of schizophrenia. Schizophr. Res. 1997, 28:111-125.
15. Karry R., Klein E., Ben Shachar D. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study. Biol. Psychiatry 2004, 55:676-684.
16. Lewis P.A., Manzoni C. LRRK2 and human disease: a complicated question or a question of complexes?. Sci. Signal. 2012, 5:pe2.
17. Li Z., Okamoto K., Hayashi Y., Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 2004, 119:873-887.
18. Liu G.H., Qu J., Suzuki K., Nivet E., Li M., Montserrat N., Yi F., Xu X.L., Ruiz S., Zhang W.Q., Wagner U., Kim A., Ren B., Li Y., Goebl A., Kim J., Soligalla R.D., Dubova I., Thompson J., Yates J., Esteban C.R., Sancho-Martinez I., Belmonte J.C.I. Progressive degeneration of human neural stem cells caused by pathogenic LRRK2. Nature 2012, 491:603-607.
19. Loranger A.W. Sex difference in age at onset of schizophrenia. Arch. Gen. Psychiatry 1984, 41:157-161.
20. Ma L., Tang J., Wang D., Zhang W., Liu W., Wang D., Liu X.H., Gong W., Yao Y.G., Chen X. Evaluating risk loci for schizophrenia distilled from genome-wide association studies in Han Chinese from Central China. Mol. Psychiatry 2013, 18:638-639.
21. Ma L., Zhang W., Tang J., Tan L., Yao Y.G., Chen X. No association between genetic polymorphisms of the NDUFS7 gene and schizophrenia in Han Chinese. Psychiatr. Genet. 2013, 23:29-32.
22. Mata I.F., Wedemeyer W.J., Farrer M.J., Taylor J.P., Gallo K.A. LRRK2 in Parkinson's disease: protein domains and functional insights. Trends Neurosci. 2006, 29:286-293.
23. Maurer I., Zierz S., Moller H. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr. Res. 2001, 48:125-136.
24. Munakata K., Iwamoto K., Bundo M., Kato T. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia. Biol. Psychiatry 2005, 57:525-532.
25. Papkovskaia T.D., Chau K.Y., Inesta-Vaquera F., Papkovsky D.B., Healy D.G., Nishio K., Staddon J., Duchen M.R., Hardy J., Schapira A.H., Cooper J.M. G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization. Hum. Mol. Genet. 2012, 21:4201-4213.
26. Rapoport J.L., Giedd J.N., Gogtay N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry 2012, 17:1228-1238.
27. Robicsek O., Karry R., Petit I., Salman-Kesner N., Muller F.J., Klein E., Aberdam D., Ben-Shachar D. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol. Psychiatry 2013, 18:1067-1076.
28. Rosenfeld M., Brenner-Lavie H., Ari S.G., Kavushansky A., Ben-Shachar D. Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol. Psychiatry 2011, 69:980-988.
29. Rubio J.P., Topp S., Warren L., St Jean P.L., Wegmann D., Kessner D., Novembre J., Shen J., Fraser D., Aponte J., Nangle K., Cardon L.R., Ehm M.G., Chissoe S.L., Whittaker J.C., Nelson M.R., Mooser V.E. Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p. Arg1628Pro mutation in Europe. Hum. Mutat. 2012, 33:1087-1098.
30. Saunders-Pullman R., Barrett M.J., Stanley K.M., Luciano M.S., Shanker V., Severt L., Hunt A., Raymond D., Ozelius L.J., Bressman S.B. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease. Mov. Disord.: Off. J. Mov. Disord. Soc. 2010, 25:2536-2541.
31. Sequeira A., Martin M.V., Rollins B., Moon E.A., Bunney W.E., Macciardi F., Lupoli S., Smith E.N., Kelsoe J., Magnan C.N., van Oven M., Baldi P., Wallace D.C., Vawter M.P. Mitochondrial mutations and polymorphisms in psychiatric disorders. Front. Genet. 2012, 3:103.
32. Stephens M., Smith N.J., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68:978-989.
33. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch. Gen. Psychiatry 2003, 60:1187-1192.
34. Tang W., Cai J., Yi Z., Zhang Y., Lu W., Zhang C. Association study of common variants within the G protein-coupled receptor kinase 6 gene and schizophrenia susceptibility in Han Chinese. Hum. Psychopharmacol. 2014, 29:100-103.
35. Tsika E., Moore D.J. Mechanisms of LRRK2-mediated neurodegeneration. Curr. Neurol. Neurosci. Rep. 2012, 12:251-260.
36. Vitte J., Traver S., Maués De Paula A., Lesage S., Rovelli G., Corti O., Duyckaerts C., Brice A. Leucine-rich repeat kinase 2 is associated with the endoplasmic reticulum in dopaminergic neurons and accumulates in the core of Lewy bodies in Parkinson disease. J. Neuropathol. Exp. Neurol. 2010, 69:959-972.
37. Wang D., Feng J.Q., Li Y.Y., Zhang D.F., Li X.A., Li Q.W., Yao Y.G. Genetic variants of the MRC1 gene and the IFNG gene are associated with leprosy in Han Chinese from Southwest China. Hum. Genet. 2012, 131:1251-1260.
38. Wang X., Yan M.H., Fujioka H., Liu J., Wilson-Delfosse A., Chen S.G., Perry G., Casadesus G., Zhu X. LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1. Hum. Mol. Genet. 2012, 21:1931-1944.
39. Zhang F.R., Huang W., Chen S.M., Sun L.D., Liu H., Li Y., Cui Y., Yan X.X., Yang H.T., Yang R.D., Chu T.S., Zhang C., Zhang L., Han J.W., Yu G.Q., Quan C., Yu Y.X., Zhang Z., Shi B.Q., Zhang L.H., Cheng H., Wang C.Y., Lin Y., Zheng H.F., Fu X.A., Zuo X.B., Wang Q., Long H., Sun Y.P., Cheng Y.L., Tian H.Q., Zhou F.S., Liu H.X., Lu W.S., He S.M., Du W.L., Shen M., Jin Q.Y., Wang Y., Low H.Q., Erwin T., Yang N.H., Li J.Y., Zhao X., Jiao Y.L., Mao L.G., Yin G., Jiang Z.X., Wang X.D., Yu J.P., Hu Z.H., Gong C.H., Liu Y.Q., Liu R.Y., Wang D.M., Wei D., Liu J.X., Cao W.K., Cao H.Z., Li Y.P., Yan W.G., Wei S.Y., Wang K.J., Hibberd M.L., Yang S., Zhang X.J., Liu J.J. Genomewide association study of leprosy. N. Engl. J. Med. 2009, 361:2609-2618.
40. Zhang W., Chen X., Gong W., Tang J., Tan L., Guo H., Yao Y.G. Common promoter variants of the NDUFV2 gene do not confer susceptibility to schizophrenia in Han Chinese. Behav. Brain Funct. 2010, 6:75.